期刊文献+

不同保存液对自体静脉移植后血管内膜增生的影响 被引量:2

Effects of crystalloid preservation solutions and colloid preservation solutions on intimal hyperplasia of autogenous vein
原文传递
导出
摘要 目的:探讨晶、胶体保存液对自体静脉移植后血管内膜增生的影响,以筛选出优良的移植血管保存液。方法:建立大鼠自体静脉移植模型,分为2组:晶体液保存组,术中移植静脉以晶体液保存;胶体液保存组,术中移植静脉以胶体液保存。分别于术后第1天、3天、1周、2周、4周、6周取材。对移植血管应用苏木精-伊红染色,进行组织形态学观察;应用免疫组织化学法观察增殖细胞核抗原(PCNA)、P21在移植后不同时期的表达情况。结果:晶体液保存组的静脉较胶体液保存组增厚明显;PCNA表达高峰在1~2周,晶体液保存的静脉表达较胶体液保存的静脉明显;P21在1~2周时表达水平较低,其后逐渐升高,至4周时达高峰,在同一时点,胶体液保存的静脉较晶体液保存的静脉表达明显。结论:自体静脉移植血管保存中,胶体保存液优于晶体保存液。 Objective: By building different kinds of preservation solutions on autografted vein, our purpose were to observe the different effects of crystalloid preservation solutions and colloid preservation solutions on the cases for intimal hyperplasia of graft vein on different periods. Method:To establish different rat experimental models of autogenous vein graft. The rats were divided into crystalloid preservation solution. At 1st day,3rd day, 1st week, 2nd week, 4th weel, 6th week after surgery, vein grafts were harvested. The local expression of proliferating cell nuclear antigen(PCNA), P21 was analyzed by immunohistochemical technique and showed the hyperplastic degree of vein intimal during the different period. Result: After operation the degree of graft veins in crystalloid preservation solution was thicker than in colloid preservation solution. During 1st and 2nd week, the expression of PCNA reached the highest in erystalloid preservation solution group(P〈0.05). And during 1st and 2nd week, the expression of P21 was low, and till 4th week reached the highest in eolloid preservation solution group(P〈0.05). Conclusion:In autogenous vein graft cases, colloid preservation solution was better than crystallois preservation solution.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第11期856-858,共3页 Journal of Clinical Cardiology
基金 黑龙江省科技厅攻关课题资助项目(No:GC05C40301)
关键词 移植 自体血管 晶体保存液 胶体保存液 增殖细胞核抗原 graft, autogenous vein crystalloid preservation solution colloid preservation solution proliferating cell nuclear antigen
  • 相关文献

参考文献4

  • 1WEBER T, BERENT R, KIRCHGATTERER A, et al. Coronary artery bypass graft dysfunction clinical presentation, laboratory and electrocardiographic parameters[J]. Acta Med Austriaca, 2001,28: 5- 10.
  • 2NICOLINI F A , PEPINE C J . Biology of restenosis and therapeutic approach[J]. Surg Clin North Am, 1992,72:919-940.
  • 3CHANG M W,BARR E, LU M M, et al. A denovirus-mediated over-expression of the cyclin/cyclin-deendent kinase inhibitor, P21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty[J]. J Clin Invest, 1995,96: 2260- 2268.
  • 4YANG Z Y, SIMARI R D, PERKINS N D, et al. Role of the P21 cyelin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury[J]. Proc Natrl Acad Sci USA, 1996,93 : 7905 - 7910.

同被引文献25

  • 1王怀斌,甄文俊,佟宏峰,孙耀光,马玉健,吴良洪.不同保存液对血管内皮细胞保护效果的实验研究[J].中华胸心血管外科杂志,2004,20(3):167-169. 被引量:6
  • 2Favalor R. Critical analysis of coronary artery bypass graft surgery: a 30 year journey. J Am Coil Cardiol, 1998,31 :B1-63.
  • 3Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev, 2005,85 : 1-31.
  • 4Roberts A J, Hay DA, Jawahar LM, et al. Biochmeical and ultra- structural integrity of the saphenous vein during CABG: Prelimi- nary results of the effect of papaverine. J Thoarc Cardiovasc Surg, 1984,88 : 39-45.
  • 5Wei CG, Komori K, Mori E. Natural course of the functional and morphological changes in canine autogenous arterial graft. Eur Surg Res, 2001,33 : 21-27.
  • 6Angelini GD, Christie MI, Bryant AJ, et al. Surgical preparation impairs release of endothelium derived relaxing fact or from hu- man saphenous vein. Ann Thorac Surg, 1989,48 : 417-420.
  • 7Tatoulis J, Jiang GC, Moffatt JD, et al. St orage of radial artery grafts in blood increases vessel reactivity to vasoconstrict ors in vitro. Ann Thorac Surg, 1999,68 : 2191-2195.
  • 8Cocks TM, Malta E, King SJ, et al. Oxyhem oglobin increases the product ion of endothelin-1 by endothelial cells in culture. Eur J Pharmacol, 1991,196: 177-182.
  • 9Rosenfeldt FL, He GW, Buxtno BF. Pharmacology of coronary artery bypass gatfs. Ann Thorae Surg, 1999,67 : 878-888.
  • 10Saijonmaa O, Ristimaki A, Fyhrquist F, et al. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulat ed endothelin product ion from cultured endothelialcells. Bioehem Biophys Res Commun, 1990,173:514-520.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部